Erste Asset Management Gmb H Coherus Bio Sciences, Inc. Transaction History

Erste Asset Management Gmb H

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Nov 26, 2024	SELL	$5.86 - $13.23 $161,736 - $365,148	-27,600 Closed	0 $0
Q1 2021 Nov 22, 2024	SELL	$14.42 - $21.39 $1.44 Million - $2.14 Million	-100,000 Closed	0 $0
Q3 2020 Nov 22, 2024	BUY	$17.41 - $19.89 $1.74 Million - $1.99 Million	100,000 New	100,000 $1.83 Billion
Q4 2019 Nov 22, 2024	BUY	$16.33 - $21.37 $2.55 Million - $3.33 Million	156,000 New	156,000 $2.77 Billion
Q2 2019 Nov 22, 2024	BUY	$13.1 - $22.1 $2.04 Million - $3.45 Million	156,000 New	156,000 $3.41 Billion
Q4 2018 Nov 26, 2024	BUY	$8.65 - $16.28 $238,740 - $449,328	27,600 New	27,600 $243 Million

135

77.9M

40.7K

50.1K

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $132M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

Get notified when there are updates to the investment portfolio of Erste Asset Management Gmb H, based on Form 13F filings with the SEC.

Stay updated on Erste Asset Management Gmb H with notifications on news.